You can read the full article at Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial This study investigated the effects of tirzepatide, a medication used to treat type 2 diabetes, on the bodys physiological mechanisms
Nutrition was monitored because food intake could drop a lot
For example, Mounjaro led to a higher average weight loss compared to semaglutide in clinical settings
Otherwise, talk to your provider in the following situations: Theres no best way to manage Type 2 diabetes or obesity
It also notes many people at the earliest stage report gastrointestinal adjustment rather than dramatic weight change
DOria R, Schipani R, Leonardini A, Natalicchio A, Perrini S, Cignarelli A, et al